Filter
3692
Filtered Results: 3692
Text search:
World
Health
Organization
(WHO)
&
United
States
Agency
for
International
Development
(USAID)
Featured
Recommendations
300
New Publications
1071
Language
Document type
No document type
2182
Studies & Reports
677
Guidelines
379
Manuals
207
Strategic & Response Plan
142
Training Material
48
Fact sheets
23
Situation Updates
22
Resource Platforms
6
Infographics
4
App
1
Online Courses
1
Countries / Regions
Global
179
Kenya
123
Nigeria
112
Western and Central Europe
97
Ethiopia
86
Nepal
83
Liberia
80
Uganda
73
Myanmar / Burma
67
India
66
Malawi
59
Sierra Leone
57
Ghana
56
Zambia
56
Rwanda
54
Syria
50
Bangladesh
48
Africa
46
Tanzania
45
Latin America and the Carribbean
45
Ukraine
43
Namibia
42
South Africa
41
South Sudan
38
Philippines
37
Eastern Europe
36
Zimbabwe
35
Congo, Democratic Republic of
29
Haiti
28
Indonesia
28
Senegal
27
Cambodia
27
Lesotho
27
South–East Asia Region
27
Asia
26
Guinea
25
Mozambique
17
Pakistan
16
Yemen
16
East and Southern Africa
16
West and Central Africa
16
Venezuela
16
Afghanistan
14
Eswatini/ Swaziland
14
Botswana
14
Russia
14
Thailand
13
Cameroon
12
Jordan
12
Sudan
12
Middle East and North Africa
12
Eastern Europe and Central Asia
12
Somalia
10
Lebanon
10
Colombia
10
Germany
9
Benin
9
Central African Republic
9
Brazil
9
Sri Lanka
9
USA
8
China
8
Laos
8
Burkina Faso
7
Iraq
7
Vietnam
7
Mali
6
Georgia
6
Côte d’Ivoire / Ivory Coast
5
Mexico
5
Tajikistan
5
Moldova
5
Iran
5
Turkey
4
Egypt
4
Burundi
4
Angola
4
Madagascar
4
Chad
3
Papua New Guinea
3
Peru
3
North Macedonia
3
Hungary
3
El Salvador
3
Greece
3
Western Pacific Region
3
Poland
3
Palestine
3
Armenia
3
Southern Africa
3
Kyrgyzstan
3
Turkmenistan
3
Jamaica
3
Portugal
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Malaysia
2
Argentina
2
Serbia
2
Croatia
2
Honduras
2
Bolivia
2
Libya
2
Chile
2
Paraguay
2
Bhutan
2
Albania
2
Canada
2
Bulgaria
2
Romania
2
Japan
2
Spain
2
Belarus
2
Niger
1
Togo
1
Gambia
1
Mauritania
1
Ireland
1
Singapore
1
Ecuador
1
Other region
1
Djibouti
1
Mongolia
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Slovakia
1
Kazakhstan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1289
Women & Child Health
280
Clinical Guidelines
252
Public Health
230
Key Resources
201
Capacity Building
72
Pharmacy & Technologies
50
Toolboxes
HIV
303
Mental Health
235
TB
208
Disability
198
COVID-19
195
Planetary Health
190
Conflict
148
Rapid Response
104
AMR
103
Caregiver
96
Global Health Education
78
Refugee
77
Ebola
75
Pharmacy
62
Natural Hazards
54
NTDs
54
Health Financing Toolbox
54
NCDs
44
Specific Hazards
34
Zika
19
Polio
17
Cholera
12
Social Ethics
5
South Sudan
2
Typhoon
1
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (...) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women is only recommended in the context of rigorous research.” The Guideline Development Group (GDG) made this recommendation because it felt that the evidence on the intervention was incomplete and that more research was necessary.
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met ...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The ... is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pandemic will end, recent encouraging vaccine results, in addition to the examples of countries that have achieved good results through public health measures, hold out the prospect of better days ahead. The full impact of the pandemic cannot yet be determined. But whatever its implications, the Secretariat will rise to the challenge and is ready to adapt so that it is fully equipped to support Member States for any eventuality in the future – to make sure that the world will never again have to face this kind of crisis.
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
A practical guide for hospital administrators, health disaster coordinators, health facility designers, engineers and maintenance staff to achieve ...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an update...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded p...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others ... are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact.
The operational handbook provides practical information and tools that complement the recommendations in the guidelines. The strategies described in the operational handbook are based on the latest WHO recommendations which were formulated by Guideline Development Groups using the GRADE approach. In many cases however, the recommendations in their current form lacked sufficient clinical and programmatic detail, which is important for implementation. This operational handbook complements the guidelines with practical advice based on best practices and knowledge from the fields such as pharmacokinetics, pharmacodynamics, microbiology, pharmacovigilance and clinical and programmatic management.
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four hea... outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting of the Sustainable Development Goal indicator 3.9.2. The report includes estimates at global, regional and country level for 183 WHO Member States.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
This Community Health Systems (CHS) Catalog country profile is the 2016 update of a landscape
assessment that was originally conducted by the Advancing Partners & Communities (APC) project
in 2014. The CHS Catalog focuses on 25 countries deemed pr...
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s p...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision...
The Global status report on violence prevention 2014, which reflects data from 133 countries, is the first report of its kind to assess national efforts to address interpersonal violence, namely child maltreatment, youth violence, intimate partner and sexual violence, and elder abuse. Jointly publis...
The goal of this assessment is to determine how far USAID/Senegal’s HIV/AIDS and TB programs have achieved their specific objectives with regard to identifying potential leads for improvement that are likely to make it easier to reach the planned ...
Following the release of the Wheelchair Service Training Package – Basic level (WSTP-B), WHO in partnership with United States ... for International Development (USAID) has developed the Wheelchair Service Training Package – Intermediate Level (WSTP-I). WSTP-I is the second part of the WHO wheelchair service training package series and focusses more on addressing the needs of people who have severe difficulties in walking and moving around and also having poor postural control . While developing this training package, special attention was given on the provision of appropriate wheelchairs for children who have poor postural control and are unable to sit upright independently.
Purpose of the training
The need for wheelchair personnel is universal. WSTP-I is designed to support the training of personnel or volunteers to provide an appropriate manual wheelchair and cushion for children and adults who need additional postural support to sit upright. The main purpose of this training package is to:
increase the number of wheelchair users who receive a wheelchair which meets their needs;
increase the number of personnel trained in intermediate level wheelchair service delivery;
improve the competencies of wheelchair service delivery personnel;
increase the quality of wheelchair service delivery for people who need a comparatively higher level of intervention than basic level;
include this training package in regular paramedical/rehabilitation training programmes;
achieve greater integration of wheelchair service delivery within rehabilitation services.
The United States Agency for International ... (USAID) Bureau for Democracy, Conflict, and Humanitarian Assistance Office of U.S. Foreign Disaster Assistance (DCHA/OFDA) requested Food and Nutrition Technical Assistance II Project (FANTA-2) assistance to review Community-Based Management of Acute Malnutrition (CMAM) in four West African countries—Burkina Faso, Mali, Mauritania, and Niger—to help identify DCHA/OFDA 2010 and 2011 program priorities, including where DCHA/OFDA investment should be directed to support CMAM. The goal was to review CMAM program implementation and its integration into national health systems to provide DCHA/OFDA a status report for each country; draw lessons learned; and make recommendations on challenges, promising practices, gaps, and priority areas for DCHA/OFDA support during 2010 and 2011. The review was intended for DCHA/OFDA program planning purposes and also potentially as an advocacy tool to guide other donors in planning CMAM support in the region. After all four countries have been reviewed, FANTA-2 will develop a synthesis report. The current document presents a summary report on CMAM in Burkina Faso only.
